The multifunctional and multi-system influence of Ghrelin in the treatment of diabetic and spinal cord injury induced Neuropathy

Ghrelin (Gh), a small peptide, which was originally discovered as a gastrointestinal (GI) tropic hormone, has shown to have a presence and function within multiple tissue systems. Recently, Gh has shown to exhibit anti-inflammatory and regenerative abilities in response to both chemical and mechanical stressors within neural tissues. By continuing to elucidate the potential applications of Gh on pathological neural states, the viability of this peptide hormone for therapeutic uses can be explored for future clinical application.

• Publication year

  2011

• Venue

  Annals of Neurosciences

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5214/ans.0972.7531.1118309PMID 25205937PMCID 4116944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Double and triple spikes in C‐nociceptors in neuropathic pain states: An additional peripheral mechanism of hyperalgesia

  2011cited by this paper
• Ghrelin inhibits hydrogen peroxide-induced apoptotic cell death of oligodendrocytes via ERK and p38MAPK signaling.

  2011cited by this paper
• Role of the NKCC1 co‐transporter in sensitization of spinal nociceptive neurons

  2010cited by this paper
• Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats.

  2010cited by this paper
• Gabapentin for the treatment of cancer-related pain syndromes.

  2010cited by this paper
• Emerging drugs for diabetic neuropathy

  2010cited by this paper
• Neuropathic pain: clinical features, assessment and treatment.

  2010cited by this paper
• Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia

  2010cited by this paper
• Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain.

  2010cited by this paper
• Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury.

  2010cited by this paper
• Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury

  2010cited by this paper
• Transitional change in rat fetal cell proliferation in response to ghrelin and des-acyl ghrelin during the last stage of pregnancy.

  2010cited by this paper
• Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies

  2009cited by this paper
• Desacyl‐ghrelin and synthetic GH‐secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by β‐amyloid fibrils

  2009cited by this paper
• Neuropathic Pain Syndromes

  2008cited by this paper
• GABA receptor activation in the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injured rats.

  2008cited by this paper
• The gastrointestinal hormone ghrelin modulates inhibitory neurotransmission in deep laminae of mouse spinal cord dorsal horn.

  2008cited by this paper
• The role of cation-dependent chloride transporters in neuropathic pain following spinal cord injury

  2008cited by this paper
• The role of inflammatory cytokines in diabetes and its complications.

  2008cited by this paper
• Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms.

  2007cited by this paper
• Ghrelin may attenuate proinflammatory cytokine-mediated neuropathic pain.

  2007cited by this paper
• Challenges in the development of novel treatment strategies for neuropathic pain

  2005cited by this paper
• Diabetes and its complications

  2005cited by this paper
• Medical evaluation and treatment of diabetic peripheral neuropathy.

  2003cited by this paper
• Activation of NKCC1 by hyperosmotic stress in human tracheal epithelial cells involves PKC-delta and ERK.

  2002cited by this paper
• Partial Peripheral Nerve Injury Promotes a Selective Loss of GABAergic Inhibition in the Superficial Dorsal Horn of the Spinal Cord

  2002cited by this paper
• Pathobiology of neuropathic pain.

  2001cited by this paper
• Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy.

  1999cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999cited by this paper
• Free radicals and reactive oxygen species in programmed cell death.

  1999cited by this paper
• Postinjury neuropathic pain syndromes.

  1999cited by this paper
• Assessment and Treatment

  1982cited by this paper
• Journal of Neuroinflammation Open Access Research Key Role for Spinal Dorsal Horn Microglial Kinin B 1 Receptor in Early Diabetic Pain Neuropathy

  year unknowncited by this paper

• Mechanism of gastrointestinal injury in COVID-19 and potential use of ghrelin therapy

  2023cites this paper
• The Burden of Peripheral Neuropathy in Nondiabetic Chronic Kidney Disease and the Role of Ghrelin Isoforms in its Development

  2022cites this paper
• Ghrelin-Mediated Regeneration and Plasticity After Nervous System Injury

  2021cites this paper
• The active fragments of ghrelin cross the blood-brain barrier and enter the brain to produce antinociceptive effects after systemic administration.

  2021cites this paper
• Effect of unacylated ghrelin on peripheral nerve regeneration

  2021cites this paper
• A Systematic Review of Growth Hormone in Pain Medicine: From Rodents to Humans.

  2019cites this paper
• GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study

  2018cites this paper
• Ghrelin inhibits hydrogen peroxide-induced apoptotic cell death of oligodendrocytes via ERK and p38MAPK signaling.

  2011cites this paper
• Gabapentin for the Treatment of Cancer-Related Pain Syndromes

  2010cites this paper